ArtBlood

Private

SeoulHealthcare & Life Scienceshttp://artblood.kr/

Last Round

Series B

Nov 1, 2025

Total Funding Raised

$20.84M

Company Overview

ArtBlood is a biotechnology company that develops a cell-based in vitro blood production system intended to solve the problem of blood transfusion shortages.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

artificial bloodlab-grown bloodsynthetic bloodred blood cellsstem cell therapybiotechnologydrug delivery platformdiagnostic reagentscell-line engineeringbioreactor productioncGMP manufacturingblood transfusionex vivo productioncell therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ArtBlood Comps

Public and private peers based on sector, stage, and business model.

ArtBlood comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ArtBlood Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Nov 1, 2025
Series A	Sep 24, 2024
Series A	Apr 9, 2024
Grant	Aug 1, 2023
Seed	Jul 1, 2022

View all Funding Rounds

ArtBlood Investors

Notable investors and investment history

ArtBlood investors
Investor	Rounds
Korea Investment Accelerator	Series A
Korea Investment Accelerator	Series A
Heungkuk Securities	Series A
Korea Development Bank	Series A
Ministry of Health and Welfare (South Korea)	Grant
Partners Investment	Series A
SERIES Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 9, 2024
$8M round led by Heungkuk Securities and Partners Investment.

View all signals

ArtBlood Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ArtBlood Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ArtBlood's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Year Founded2022

Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.